Alema Galijatovic-Idrizbegovic

Statistics

Publications

Citations

125

H-Index

Active since

2007

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Alema Galijatovic-Idrizbegovic is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and toxicology.

Publications per year

2007–2024

Publications

A highly sensitive canine telemetry model for detection of QT interval prolongation: Studies with moxifloxacin, haloperidol and MK-499

Alyssa Chaves, Gloria J. Zingaro, Michael Yordy et al. · Journal of Pharmacological and Toxicological Methods · 2007 · 35 citations

Medicine, Pharmacology, Veterinary Pharmacology +5

Antibiotic-induced Elevations of Plasma Bile Acids in Rats Independent of Bsep Inhibition

Yutai Li, Michael J. Hafey, Hong Duong et al. · Toxicological Sciences · 2017 · 24 citations

Medicine, Biochemistry, Pharmacology +17

Role of chronic toxicology studies in revealing new toxicities

Alema Galijatovic-Idrizbegovic, Judith E. Miller, Wendy D. Cornell et al. · Regulatory Toxicology and Pharmacology · 2016 · 19 citations

Pharmacy, Toxicology, Environmental Toxicology +11

Pharmacological efficacy and safety profile of taranabant in preclinical species

Tung M. Fong, Lauren P. Shearman, D. Sloan Stribling et al. · Drug Development Research · 2009 · 18 citations

Medicine, Pharmacology, Toxicology +14

N-nitrosamine impurity risk assessment in pharmaceuticals: Utilizing In vivo mutation relative potency comparison to establish an acceptable intake for NTTP

Mark W. Powley, Zhanna Sobol, George E. Johnson et al. · Regulatory Toxicology and Pharmacology · 2024 · 18 citations · Full text

Pharmacy, Pharmacology, Toxicology +14

1–5 of 6